OPKO Health to Report First Quarter 2026 Financial Results on April 28, 2026
OPKO Health (NASDAQ: OPK) will report first quarter 2026 operating and financial results for the period ended March 31, 2026 after market close on April 28, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
OPKO Health (NASDAQ: OPK) will report first quarter 2026 operating and financial results for the period ended March 31, 2026 after market close on April 28, 2026.
Management will host a conference call and live audio webcast on April 28 at 4:30 p.m. Eastern to discuss results and financial guidance. Telephone replay and webcast replay will be available through early May.
Details
News Market Reaction – OPK
On Apr 22, the first trading day after this news, OPK closed 0.82% above the previous close.
Data tracked by StockTitan Argus for the Apr 22 session.
Key Figures
- Results period end
- March 31, 2026
- Quarter to be reported (Q1 2026)
- Earnings release date
- April 28, 2026
- Planned release after U.S. market close
- Conference call time
- 4:30 p.m. Eastern
- Start time for Q1 2026 results call
- Replay availability
- Until May 5, 2026
- Telephone replay window for earnings call
- Replay passcode
- 2140261
- Code required to access telephone replay
Previous Earnings date Reports
-
Announced date and call details for Q4 2025 results and guidance.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
MIAMI, April 21, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2026 after the close of the U.S. financial markets on Tuesday, April 28, 2026. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on April 28th beginning at 4:30 p.m. Eastern time.
CONFERENCE CALL & WEBCAST INFORMATION
OPKO encourages participants to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed at OPKO’s Investor Relations page and here.
A telephone replay will be available until May 5, 2026, by dialing 855-669-9658 (U.S.) or 412-317-0088 (International) and providing the passcode 2140261. A webcast replay will be available beginning approximately one hour after the completion of the live conference call here.
About OPKO Health
OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.
Contacts:
Alliance Advisors IR
Yvonne Briggs, 310-691-7100
ybriggs@allianceadvisors.com
or
Bruce Voss, 310-691-7100
bvoss@allianceadvisors.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.